Jul 1 |
Unicycive Therapeutics joins Russell Microcap Index
|
Jul 1 |
Unicycive Therapeutics Joins Russell Microcap® Index
|
Jun 25 |
Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Trial
|
Jun 21 |
When Can We Expect A Profit From Unicycive Therapeutics, Inc. (NASDAQ:UNCY)?
|
May 28 |
Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress
|
May 15 |
Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical Meeting
|
May 14 |
Unicycive Therapeutics reports Q1 GAAP EPS of -$0.61
|
Apr 29 |
These 2 ‘Strong Buy’ Penny Stocks Could Rally to $9, Says Piper Sandler
|
Mar 28 |
Unicycive Therapeutics GAAP EPS of -$1.28, revenue of $0.7M
|
Mar 28 |
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update
|